15 June 2017
NAICONS Team Discover New Antibiotic Effective against Drug-Resistant Bacteria.
Scientists from Rutgers University-New Brunswick, NAICONS and elsewhere report in Cell today the discovery and mechanism of action of a new antibiotic effective against drug-resistant bacteria. See EurekAlert for further details>
Apr. 2017 NAICONS CEO to speak at ECCMID 2017 (Vienna 22nd – 25th April) read more>
Feb. 2017 NAICONS awards PREMIO-NAICONS read more>
Jan. 2017 NAICONS takes part in Rafts4Biotech (Synthetic bacterial lipid rafts to optimize industrial bioprocesses), funded by the European Commission under the Horizon 2020, H2020-NMBP-BIO-2016 (no. 720776) For more info about project see read more about Rafts4Biotech>
Jan. 2017 NAICONS takes part in TOPCAPI (Thoroughly Optimised Production Chassis for Advanced Pharmaceutical Ingredients), funded by the European Commission under the Horizon 2020, H2020-NMBP-BIO-2016 (no. 720793).
Jan. 2017 NAICONS takes part in Train2Target, an European Training Network funded by the European Commission under the Horizon 2020 Marie Skłodowska-Curie Action (no. 721484). The project, which started on January 2017 and will last until December 2020, involves 11 Beneficiaries from 8 different countries and is dedicated to the scientific and professional training of 15 Early Stage Researchers (PhDs). the aim of the Train2Target programme is to deliver leads for a new generation of innovative antibacterials to treat infections by multi-drug resistant pathogens. For more info about project see read more about train2target>
Feb. 2016 "Premio NAICONS 2016" read more>
Jan. 2016 "NAICONS signs Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance " read more>
Dec. 2015 "NAICONS Transfers Entire Fungi Collection to Koch Biological Solutions" read more>
Apr. 2015 "NAICONS joins BEAM alliance" read more>